Biomatics Capital
Seattle, Washington, United States · Series B
Their stated focus (public profile)
Biomatics Capital invests in companies at the convergence of genomics and digital data, focusing on therapeutics, diagnostics, and delivery models. The fund backs breakthrough science transforming medicine into a value-based healthcare system aimed at lower costs and better patient outcomes. Biomatics targets the next generation of companies leading this transformation, with a focus on areas such as gene editing, DNA synthesis, and digital health.
Stages: Series B
Sectors: Medtech, Healthtech, Life sciences, Proteomics
On file: 13 companies on record
Website: biomaticscapital.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.